External Link

You are now leaving the Grünenthal (IE) website. You will be re-directed to an external website. Grünenthal Pharma Ltd., Ireland accepts no responsibility for the content of other websites.

Compliance, Ethics & Transparency

We focus on ensuring an ethical business culture including adherence to legal requirements and industry standards, the responsible use of Artificial Intelligence, and addressing industry specific risks such as corruption and bribery.

 

Providing a framework for our action

Compliance

Our compliance system provides a clear framework for our decisions. By applying our reasonable judgement and by being guided by our company values, we all contribute to conducting business at the highest standards and maintaining Grünenthal’s good reputation.

Audit

Internal Audit is an independent and objective assurance and consulting function that helps Grünenthal achieve its objectives. During audits the effectiveness of its control and governance processes are assessed and areas for improvement identified.

Risk

Effective, efficient and secure processes are the basis for a company’s successful performance. Risk Management works closely with different business areas to ensure risks are identified, assessed and mitigated according to strategic objectives.

Hannah Engels, Global Compliance & Responsibility Officer
Our ethical framework creates clarity for our employees to help them make the right decisions and do the right thing.
Hannah Engels Global Compliance, & Responsibility Officer

Compliance

Code of Conduct

The Grünenthal Code of Conduct sets out our commitment to the highest ethical standards. Everybody in our organisation has the responsibility to live up to these standards in their daily work. All employees sign the Code of Conduct when joining Grünenthal.

Code of Conduct for Business Partners

We are committed to ethical business practices, and we only work with business partners who uphold the same high standards. To ensure this, we established our Code of Conduct for Business Partners, which must be signed before formally entering into a partnership.

Ethics Helpline

We encourage everyone to report any questions, doubts or suspicions they may have by contacting our Ethics Helpline. The confidential internet-based platform can be used 24/7. 
Every complaint or concern is investigated by our Compliance team. We take appropriate action whenever necessary.
We encourage the reporting of misconduct through our internal reporting channels. However, countries have designated authorities that serve as channels for whistleblowers. Please find a list of external reporting channels here.

Ethical Business

Responsible Use of Opioids

Grünenthal’s Charter on the Responsible Use of Opioids sets out our commitment to exploring and endorsing measures that minimise the risk of inappropriate and illegitimate use of prescription opioids – while striving to ensure that individual patients with a clear need for opioid-based pain relief are not denied access.

Anti-Corruption

We are committed to conducting business in a legal, ethical and honest manner. We have a strict Anti-Corruption Policy, a Fair Market Value Tool and strict approval processes for transfers of value. These measures ensure that we do not tolerate corruption in any form.

Digital Responsibility and Data Protection

We handle all personal data responsibly. We conduct all of our data processing activities in line with applicable legal standards such as the GDPR, and we also adhere to the principles laid out in our Digital Ethics Charter and Data Protection Policy.

Bio Ethics Framework

We are committed to conducting our research activities in line with our strict Bio Ethics Framework. We adhere to clear rules for animal testing, human biological sampling and the use of other emerging technologies.

Transparency

Sponsorship Statement

Support provided to patient organisations is not disclosed within the central report. To see details of the support provided by Grünenthal to patient organisations and other groups in our local community, please click here.

Disclosure of Transfers of Value

The Irish Pharmaceutical Healthcare Association (IPHA) (Transfers of Value - IPHA) has stipulated in its Code of Practice for the Pharmaceutical Industry that member companies disclose their data in a central report hosted by IPHA. Information regarding the disclosure of transfers of value in Ireland can be accessed directly from the IPHA website.

M-N/A-IE-07-25-0006 December 2025